Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

pharmatimes.com

PharmaTimes: News RSS

Get the latest updates from PharmaTimes: News RSS directly as they happen.

Follow now 137 followers

Latest posts

Last updated 3 days ago

Bayer begins phase 2 trial of new Alport syndrome therapy

3 days ago

New study to test Sema3A antibody in rare genetic kidney disease

Johnson & Johnson wins EU approval for new gMG treatment

3 days ago

Nipocalimab authorised for adults with antibody-positive generalised myasthenia gravis

Pharvaris reports positive phase 3 results for HAE treatment

4 days ago

Deucrictibant shows rapid symptom relief and strong safety profile in RAPIDe-3 study

AlzeCure secures EU grant for Alzheimer’s drug trial

4 days ago

Funding supports phase 2 study of NeuroRestore ACD856 in patients

Vandria reports positive phase 1 data for Alzheimer’s drug candidate

5 days ago

Company highlights safety and target engagement results for VNA-318 at CTAD meeting

HSE approves new treatment for hidradenitis suppurativa and axial spondyloarthritis

10 days ago

Bimekizumab offers fresh option for patients with chronic conditions

MSD to acquire Cidara after positive phase 2b trial results

10 days ago

hVIVO celebrates landmark deal highlighting its role in advancing influenza therapy

eXmoor Pharma and Royal Free London link to strengthen UK gene therapy manufacturing pathway

11 days ago

eXmoor Pharma and Royal Free London NHS Foundation Trust have announced a...

Alzheimer’s prevention charity pioneers research on nutrition biomarkers to detect risk

11 days ago

Foundation’s test to be used in Oxford-led blood biomarker trial

NICE recommends vutrisiran for adults with ATTR-CM in final draft guidance

12 days ago

First long-acting therapy with three-monthly dosing to target root cause of cardiac...

FDA approves Keytruda and Keytruda Qlex with Padcev for bladder cancer

12 days ago

First PD-1 inhibitor plus ADC regimens for cisplatin-ineligible patients

Academy and Wellcome strengthen partnership with £27m agreement to boost UK health research

13 days ago

Five-year deal aims to support UK biomedical talent and drive collaboration across...